Medtronic Cardiac Surgery Products Registry

This study is an observational registry designed to track the long-term performance of Medtronic's Surgical Heart Valve Repair Products and Surgical Heart Valve Replacement Products. It aims to understand any unique ways these devices might fail and identify trends in side effects over time. You may be able to join if you have, or are planned to receive, one of these eligible Medtronic products and provide written consent. The study plans to enroll about 2700 participants. The main goals are to identify device failure modes and adverse effects over a 10-year period. The current recruitment status is unclear.

Study design
This is an observational study, meaning researchers will collect information without giving you a specific treatment. It plans to include about 2700 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 10 years to identify device failure modes and adverse effects.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04073420

Medtronic Cardiac Surgery PMCF Registry

Recruiting
Not specifiedAll AgesObservational
Medtronic Cardiac Surgery
~2,700 participants
Updated 2026-04-13 on ClinicalTrials.gov
What's tested:Surgical Heart Valve Repair ProductsSurgical Heart Valve Replacement Products

At a glance

Recruiting sites
25 of 26 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Identify unique failure modes
Measured over 10 years
+1 more outcome measured
Valve Disease, Heart
26 sites across 17 states
Germany6
New York3
Texas2
Italy2
Georgia1
Michigan1
North Carolina1
Ohio1

Opens a ready-to-send draft in your own email app — review before sending.

  • Identify unique failure modes10 years
  • Identify trends in adverse device effects10 years